Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Top Cited Papers
- 28 January 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 445 (7129), 776-780
- https://doi.org/10.1038/nature05571
Abstract
One of two papers showing that delta-like 4/Notch signalling limits angiogenic sprouting and branching by regulating tip cell formation. In sprouting angiogenesis, specialized endothelial tip cells lead the outgrowth of blood-vessel sprouts towards gradients of vascular endothelial growth factor (VEGF)-A1,2. VEGF-A is also essential for the induction of endothelial tip cells2, but it is not known how single tip cells are selected to lead each vessel sprout, and how tip-cell numbers are determined. Here we present evidence that delta-like 4 (Dll4)–Notch1 signalling regulates the formation of appropriate numbers of tip cells to control vessel sprouting and branching in the mouse retina. We show that inhibition of Notch signalling using γ-secretase inhibitors, genetic inactivation of one allele of the endothelial Notch ligand Dll4, or endothelial-specific genetic deletion of Notch1, all promote increased numbers of tip cells. Conversely, activation of Notch by a soluble jagged1 peptide leads to fewer tip cells and vessel branches. Dll4 and reporters of Notch signalling are distributed in a mosaic pattern among endothelial cells of actively sprouting retinal vessels. At this location, Notch1-deleted endothelial cells preferentially assume tip-cell characteristics. Together, our results suggest that Dll4–Notch1 signalling between the endothelial cells within the angiogenic sprout serves to restrict tip-cell formation in response to VEGF, thereby establishing the adequate ratio between tip and stalk cells required for correct sprouting and branching patterns. This model offers an explanation for the dose-dependency and haploinsufficiency of the Dll4 gene3,4,5, and indicates that modulators of Dll4 or Notch signalling, such as γ-secretase inhibitors developed for Alzheimer’s disease, might find usage as pharmacological regulators of angiogenesis.Keywords
This publication has 30 references indexed in Scilit:
- VE‐cadherin‐CreERT2 transgenic mouse: A model for inducible recombination in the endotheliumDevelopmental Dynamics, 2006
- Common mechanisms of nerve and blood vessel wiringNature, 2005
- Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cellsNature, 2005
- Integration of Notch and Wnt signaling in hematopoietic stem cell maintenanceNature Immunology, 2005
- Notch3 is required for arterial identity and maturation of vascular smooth muscle cellsGenes & Development, 2004
- The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular systemNature, 2004
- VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodiaThe Journal of cell biology, 2003
- Mind Bomb Is a Ubiquitin Ligase that Is Essential for Efficient Activation of Notch Signaling by DeltaDevelopmental Cell, 2003
- Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesisGenes & Development, 2002
- Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brainJournal of Neurochemistry, 2001